| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |